How can HIV research better align with the realities of transgender and gender-diverse people?
PrEP failures in African programmes are rare, but some are happening in people with good adherence
Few HIV infections among PrEP users in Brazil and Mexico, but challenges in Peru
Twice-a-year injected drug shows promise for first-line HIV treatment
PrEP for women in Europe webinar: Part 2
HIV infections fell by two-thirds in England in five years
PrEP decreases HIV incidence by nearly 80% in west African men, despite suboptimal adherence
People who use drugs who are homeless good candidates for PrEP with appropriate support
PrEP for women in Europe webinar: Part 1
